UK regulator suspends Amgen rare-disease drug Tavneos for new patients
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Research updates, September 1
People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary (CRP) outcomes, according to a large observational study published in Journal of the American Heart Association.
Blood Pressure Treatment Linked to Lower Dementia Risk, Study Finds
A major trial hints that better blood pressure control may offer an unexpected benefit for brain health.
Nigerian actress, Atinuke Kareem dies from cancer
Nigerian actress, Atinuke Remilekun Kareem, better known as Atinuke Kareem, is dead. The actress died after a long battle with breast cancer.
Novartis says MS pill succeeds in two large studies
Notably, Novartis revealed that remibrutinib wasn’t associated with the kind of liver-related side effects other BTK inhibitors like it have encountered.
Gabapentin prescriptions are rising in addiction treatment despite weak evidence
Patients in addiction treatment are increasingly receiving prescriptions for the nerve pain drug gabapentin, despite a lack of evidence for its effectiveness.
National COVID-19 trends, September 1
The U.S.’s summer 2026 COVID-19 wave is in full swing. All disease tracking metrics report increased spread across the country, and the school year’s start and upcoming holiday weekend will cause…